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Ig class switch recombination (CSR) occurs by 
an intrachromosomal deletional recombination 
in B cells after activation by antigen in vivo and 
results in a switch from expression of IgM and 
IgD to expression of IgG, IgE, or IgA isotypes. 
CSR allows the generation of antibodies with 
the same antigen-binding variable region but 
with various constant regions, thereby enhanc-
ing the eff ectiveness of humoral immune re-
sponses. CSR requires the formation of DNA 
double-strand breaks (DSBs) within the donor 
μ gene switch (S) region (Sμ) and one of the 
downstream S regions, and occurs by an end-
joining type of recombination (1–3). Mammalian 
S regions vary substantially in primary sequences 
but uniformly share the features of being highly 
repetitive and G-rich on the nontranscribed 
strand. CSR is a region-specifi c recombination, 
as it can occur anywhere within the S region 
tandem repeats (4).
CSR and somatic hypermutation (SHM) of Ig 
variable region genes are initiated by activation-
induced cytidine deaminase (AID) (5), which 
converts cytosines in S regions and variable 
region genes to uracils (6–9). AID expression is 
induced in mouse splenic B cells activated to 
switch in culture, as well as in germinal center 
B cells that undergo CSR and SHM (5, 10, 11). 
Transcription through a particular S region is 
needed for CSR to the corresponding isotype, 
most likely to create a target for AID. The act 
of transcription creates single-strand DNA, the 
substrate for AID (8, 9, 12–15). Furthermore, 
transcription might increase chromatin accessi-
bility by displacing nucleosomes and altering 
histone modifi cations (16, 17), and it has been 
shown that AID associates with RNA polymerase 
II, perhaps thereby recruiting AID to transcrip-
tionally active loci (18, 19).
The uracil base resulting from AID activity 
can be removed by the ubiquitously expressed 
base excision repair (BER) enzyme uracil DNA 
glycosylase (UNG), leaving an abasic site (6, 20). 
Uracil excision by UNG is critical for CSR, as 
UNG defi ciency dramatically reduces CSR and 
the formation of DSBs in S regions (7, 11, 21). 
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Immunoglobulin (Ig) class switch recombination (CSR) is initiated by activation-induced 
cytidine deaminase (AID), which converts cytosines to uracils in switch (S) regions. Sub-
sequent excision of dU by uracil DNA glycosylase (UNG) of the base excision repair (BER) 
pathway is required to obtain double-strand break (DSB) intermediates for CSR. Since UNG 
normally initiates faithful repair, it is unclear how the AID-instigated S region lesions are 
converted into DSBs rather than correctly repaired by BER. Normally, DNA polymerase β 
(Polβ) would replace the dC deaminated by AID, leading to correct repair of the single-
strand break, thereby preventing CSR. We address the question of whether Polβ might be 
specifi cally down-regulated during CSR or inhibited from accessing the AID-instigated 
lesions, or whether the numerous AID-initiated S region lesions might simply overwhelm 
the BER capacity. We fi nd that nuclear Polβ levels are induced upon activation of splenic 
B cells to undergo CSR. When Polβ−/− B cells are activated to switch in culture, they switch 
slightly better to IgG2a, IgG2b, and IgG3 and have more S region DSBs and mutations than 
wild-type controls. We conclude that Polβ attempts to faithfully repair S region lesions but 
fails to repair them all.
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These observations indicate that UNG is the predominant, 
and perhaps only, uracil-excision enzyme involved in CSR 
and that none of the other enzymes with similar activity provide 
a signifi cant backup for UNG during CSR (22, 23). In the 
BER pathway, abasic sites are subsequently recognized by 
apurinic/apyrimidic endonucleases (APEs), which nick the 
DNA backbone to create DNA single-strand breaks (SSBs) (24). 
Recent evidence indicates that APE is important for DSB 
formation during CSR (unpublished data).
Closely spaced nicks on opposite strands could spontane-
ously lead to staggered DSBs. In addition, the U:G mismatches 
could be processed by the mismatch repair (MMR) machinery 
to create DSBs from distal SSBs on opposite strands (unpub-
lished data) (25). During the canonical BER pathway, the 
single nucleotide gap generated by the action of UNG and 
APE is fi lled in by DNA polymerase β (Polβ) and then the 
5′-deoxyribose phosphate (dRP) group remaining after APE 
activity is excised by the lyase activity of Polβ (20, 26). Sub-
sequently, DNA ligase I or DNA ligase III-XRCC1 are recruited 
to seal the gap, restoring the original DNA sequence, which, 
however, would prevent CSR. Correct repair of the AID lesion 
would also prevent SHM.
Hence, an intriguing question arises as to how the S 
region nicks are spared from faithful repair so that they can be 
converted into DSBs to provide the essential intermediates 
for CSR. One appealing hypothesis is that BER components 
downstream of UNG and APE might be down-regulated in 
cells undergoing CSR or specifi cally prevented from access-
ing S region lesions. As Polβ is recruited by APE1, the major 
APE in cells, and the Polβ lyase activity is the rate-limiting 
step of BER (20, 27), it is possible that the levels of Polβ 
or its activity might be inhibited during CSR and SHM. 
Indeed, the recent fi nding that the amount of Polβ is inversely 
correlated with the frequency of SHM in subclones of the 
human BL2 cell line makes this hypothesis even more attrac-
tive (28). Alternatively, it is possible that the introduction of 
numerous S region lesions overwhelms the BER machinery, 
although BER activity is not inhibited during CSR. To 
address this issue, we have investigated the potential role that 
Polβ might have by examining the eff ect of Polβ defi ciency 
on CSR in splenic B cells induced to undergo CSR in culture. 
We fi nd that polβ−/− B cells manifest moderately increased 
CSR to IgG2a, IgG2b, and IgG3, but there was no eff ect on 
CSR to IgG1 and IgA, the S regions of which bear the greatest 
numbers of AID target (AGCT) hotspots. Ligation-mediated 
PCR (LM-PCR) experiments reveal that Polβ defi ciency 
increases the induction of DSBs at both donor and acceptor S 
regions. Additionally, recombined Sμ–Sγ3 segments and un-
rearranged Sμ segments from stimulated polβ−/− splenic B cells 
show an elevated mutation frequency with a striking bias 
toward mutation of the A:T bp, compared with WT cells. In 
light of these observations, we propose that Polβ normally 
competes with CSR by performing faithful repair of S region 
lesions, thereby reducing S region DSBs; therefore, Polβ 
might inhibit CSR when AID-instigated breaks in S regions 
are limiting.
RESULTS
Expression of Pol𝛃 and its localization 
at S regions in switching B cells
To gain some insight into the potential regulation of Polβ 
activity in switching B cells, we examined levels of Polβ 
protein in mouse splenic B cells induced to undergo CSR. 
B cells from WT and AID-defi cient mice were treated with 
LPS plus IL-4 or with LPS plus IFN-γ for various time periods, 
and whole-cell lysates were prepared for Western blots. We 
postulated that if any mechanisms exist in switching B cells 
to specifi cally reduce Polβ levels, such mechanisms are likely 
to be AID dependent. AID expression is greatly induced in 
splenic B cells 2 d after stimulation to switch (11). Fig. 1 A 
shows that over the course of 3 d, the levels of Polβ in 
whole-cell extracts did not change in WT or aid−/− cells. 
To determine whether Polβ might be excluded from the 
nuclei of switching B cells, we examined nuclear and cyto-
plasmic extracts from the cultured B cells. However, we 
instead observed nuclear accumulation of Polβ in cells under-
going CSR, and cytoplasmic Polβ was coincidently reduced, 
suggesting that Polβ was redistributed from the cytoplasm to 
the nucleus in switching B cells (Fig. 1 B). Blots of the WT 
nuclear and cytoplasmic extracts incubated with antibody 
to GAPDH and lamin A/C, respectively, demonstrate that 
the extracts are not cross-contaminated (Fig. S1, available at 
http://www.jem.org/cgi/content/full/jem.20070756/DC1). 
Polβ nuclear translocation was not AID dependent, as Polβ 
underwent similar translocation in AID-defi cient B cells (un-
published data). This translocation might be caused by the 
requirement for BER to repair the large amount of oxidative 
DNA damage occurring in rapidly proliferating B cells (29).
We considered the possibility that Polβ might be pre-
vented from accessing S regions in switching B cells. To 
address this, we used chromatin immunoprecipitation (ChIP) 
to detect the association of Polβ with the Sμ region. As 
shown in Fig. 1 C, binding of Polβ to the Sμ region was 
detected in LPS plus IL-4–stimulated B cells but barely in 
ex vivo (day 0) B cells. As another control, binding of Polβ 
to the constant region of IgA heavy chain (Cα) gene, which 
is not involved in CSR, was not detectable under the same 
conditions. To obtain quantitative results, ChIP was also ana-
lyzed by real-time PCR (Fig. 1 D). Stimulation with LPS 
plus IL-4 for 3 d resulted in a 2.6-fold enrichment of Polβ 
association with the Sμ region compared with ex vivo B cells, 
whereas no signifi cant enrichment was observed upon 
treatment with IL-4 plus anti-IgD conjugated to dextran 
(α-δ-dex), a treatment that induces B cell proliferation but 
not CSR. In fact, the latter treatment resulted in the same 
amount of association of Polβ with Sμ as the no antibody 
control. Fig. 1 D also shows that Polβ does not associate with 
the Cμ gene in either ex vivo or LPS plus IL-4–activated 
B cells, consistent with previous data showing that AID-
 dependent DSBs are found in S regions but not in the Cμ gene 
(11, 30, 31). Collectively, these results clearly indicate that 
Polβ localizes to nuclei and binds the Sμ region during CSR 
in cultured B cells.
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Pol𝛃-defi cient splenic B cells have a moderately 
increased ability to undergo CSR
As Polβ-defi cient mice die just before birth, to generate mice 
with polβ−/− B cells, 2 × 106 fetal liver cells (FLCs) from 
polβ−/− and from polβ+/+ day 18.5 postcoitum fetuses were 
injected intravenously into lethally irradiated recipient mice, 
as previously described (32). Because the recipient cells bear 
CD45.1 and the donor cells bear CD45.2, successful re-
constitution could be verifi ed by FACS analysis with antibodies 
recognizing CD45.1 and CD45.2. Splenic B cells from donor 
mice, but not from recipient mice, were recognized by anti-
CD45.2, validating the feasibility of this approach (Fig. 2 A, 
a and b). The recipient mice were killed 6 wk after FLC 
injection; FACS analysis revealed that their splenic B cells were 
almost exclusively CD45.2+ (95–99%; Fig. 2 A, c and d), indi-
cating successful transfer and reconstitution. Lack of Polβ 
protein in splenic B cells in recipients that received polβ−/− FLC 
was confi rmed by Western blot analysis (Fig. 2 B). Analysis of 
splenic B cell subsets showed that the proportion of immature, 
marginal zone, and follicular B cells was similar between the 
polβ+/+ and polβ−/− spleens (Fig. 2 C).
We examined whether CSR in splenic B cells was aff ected 
by Polβ defi ciency in an in vitro isotype switching assay. 
We initially determined whether Polβ deficiency could 
 impair cellular proliferation, as CSR is coupled to cell di-
vision (33, 34). Splenic B cells were isolated from reconsti-
tuted mice and cultured in the presence of LPS and cytokines 
to induce CSR to IgG1, IgG2a, IgG2b, IgG3, and IgA, 
as described in Materials and methods. Surprisingly, polβ−/− 
B cells proliferated as well as polβ+/+ B cells under all of 
the conditions tested, as determined by tracking cell division 
with CFSE (Fig. 2 E) and by [3H]thymidine uptake (Fig. 2 D). 
Also, DNA content analysis showed that the cell-cycle dis-
tribution of polβ−/− cells was similar to WT cells in cultures 
treated with switch inducers, and no increase in apoptosis 
was detected (Fig. S2, available at http://www.jem.org/cgi/
content/full/jem.20070756/DC1).
If Polβ repairs SSBs during CSR, its deletion might result 
in an increase of CSR. We examined CSR to several isotypes 
and found that switching to IgG2a was increased in the 
polβ−/− B cells, but no other isotype was signifi cantly aff ected 
(Fig. 2, F and G). As isotype specifi city is regulated by germ-
line (GL) transcription, we asked if this specifi c stimulation of 
IgG2a CSR might be caused by increased levels of GL γ2a 
transcripts in polβ−/− cells but found they were not increased 
(Fig. S3, available at http://www.jem.org/cgi/content/full/
jem.20070756/DC1). Because Polβ has no known involve-
ment in other cellular pathways except BER, it is unlikely 
that Polβ defi ciency alters the signal transduction pathway 
specifi cally for IgG2a induction. S regions consist of tandem 
Figure 1. Pol𝛃 translocates to the nucleus and binds to the Ig S𝛍 
region in B cells activated to undergo CSR. (A) Western blot of whole-
cell extracts from splenic B cells from WT and aid−/− mice cultured for 
the indicated days in the presence of LPS + IL-4 or LPS + IFN-γ. Day 0 
cells are ex vivo cells. Western blots were probed with anti-Polβ and anti-
GAPDH antibodies. GAPDH was used as a loading control. (B) Western blot 
of nuclear and cytoplasmic extracts from WT splenic B cells cultured with 
LPS + IL-4 for the indicated days. Lamin A/C was used for nuclear loading 
control. (C) ChIP showing association of Polβ with Sμ, but not with Cα, 
from splenic B cells from WT mice, ex vivo or cultured for 3 d with LPS + 
IL-4. Threefold dilutions of the input and the immunoprecipitated DNA 
amplifi ed by conventional PCR were detected by ethidium bromide. 
(D) ChIP of extracts from splenic B cells, ex vivo or cultured as indicated. α-δ-
dex shows that Polβ associates with Sμ but not with Cμ. The ChIP was 
assayed by real-time PCR, and the values were calculated as in Materials 
and methods. The mean of fi ve ChIPs is shown for Sμ, and the mean of 
triplicates from one ChIP is shown for Cμ. Error bars represent the SEM. 
The “no antibody” control was not performed for the Cμ ChIP. The signifi -
cance of the difference between ex vivo cells and LPS + IL-4–treated cells 
was determined using the paired t test.
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repeats that are unique to each isotype, although all contain 
numerous targets for AID (e.g., the hotspot motif WRC/
GYW, where W = A or T and R = G or A) (14, 35, 36). 
We considered the possibility that IgG2a CSR might be in-
hibited by Polβ because of the fact that there are fewer AID 
hotspot targets in Sγ2a than in other S regions (Table S1), 
Figure 2. Pol𝛃-defi cient B cells show a moderate increase in CSR 
to IgG2a. (A) Splenic B cells from recipient (a) and donor (b) mice or from 
recipient mice that had received liver cells of polβ+/+ or polβ−/− fetuses 
(c and d) were cultured for 3 d and stained with anti-CD45.2 antibody 
and analyzed by fl ow cytometry. The horizontal lines represent the fl uo-
rescence intensity corresponding to positively staining (i.e., CD45.2+) cells. 
Fluorescence intensity (FI) values are shown. (B) Western blot of Polβ 
expression in splenic B cells, cultured with LPS + IL-4, from mice that had 
received polβ+/+ or polβ−/− FLCs. Whole-cell lysates were prepared from 
day-3 cultures. (C) Splenic cells from WT and polβ−/− mice were simulta-
neously stained with anti-B220, anti-CD24, anti-CD21, and anti-CD23 
antibodies and analyzed by fl ow cytometry. (top) The gated cells represent 
immature cells, and (bottom) an analysis of B220+ cells is shown. FI val-
ues are shown. FO, follicular cells; MZ, marginal zone. (D) [H3]thymidine 
incorportation to measure DNA synthesis in splenic B cells cultured to 
induce switching to the indicated isotypes at 105 cells/ml for 3 d in a 
96-well plate. During the fi nal 4 h, each well was pulsed with 1 μCi 
[3H]thymidine (2 Ci/mmol; MP Biomedicals). Plates were harvested onto 
fi lter mats (LKB Wallac) and read on a 1205 Betaplate (LKB Wallac). Data 
shown are the mean cpm of quadruplicate wells. (E) CFSE-stained B cells 
were cultured for 3 d to induce switching to the indicated isotypes and 
assayed by fl ow cytometry. The graphs were analyzed by FlowJo software. 
(F) Representative FACS analysis for surface Ig isotype expression in 
transferred CD45.2+ cells. WT and polβ−/− splenic B cells were stimulated 
under optimal conditions, as described in Materials and methods for 4 d, 
and surface stained with anti-CD45.2 antibody and the antibodies recog-
nizing different Ig isotypes. The stained cells were analyzed by fl ow 
 cytometry. FI values are shown. (G) Percentage of switching to the indicated 
isotypes by polβ−/− cells relative to WT cells (set at 100%). The mean of 
four experiments is shown, and error bars represent the SEM. **, P < 0.01 
using the paired t test to determine the signifi cance of the difference 
between WT and polβ−/− switching for IgG2a.
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and thus, it was possible that SSBs might be limiting for 
IgG2a CSR but not for other isotypes. To test this hypo-
thesis, we developed suboptimal conditions for CSR for each 
isotype, by reducing the concentration of LPS and cytokines 
in culture (see Materials and methods), and examined CSR 
under these conditions in polβ−/− cells and WT controls. We 
reasoned that under suboptimal conditions, DNA breaks 
might be limiting, and thus, Polβ might inhibit CSR. Under 
suboptimal conditions, lower levels of AID and GL γ1 and 
γ3 transcripts were induced in both WT and polβ−/− cells 
(Fig. 3, C and D). As expected, suboptimal conditions resulted 
in decreased CSR effi  ciency, but polβ−/− cells switched 
relatively better than polβ+/+ cells to IgG2b, IgG3, and IgG2a 
(Fig. 3, A and B). However, CSR to IgG1 and IgA still did 
not diff er between WT and Polβ-defi cient cells. This might 
be because of the fact that Sγ1 and Sα sequences have more 
of the hottest of the AID hotspots (AGCT) (37, 38) than any 
other S region except for Sμ (Table S1).
More DSBs in S regions from Pol𝛃-defi cient B cells
If Polβ possesses the ability to repair SSBs in S regions, as we 
hypothesize, its deletion should result in the accumulation of 
SSBs and, consequently, an increased formation of DSBs. We 
used LM-PCR to detect the DSBs in Sμ and Sγ3 regions 
from polβ−/− and WT B cells. Splenic B cells were activated 
to switch for 47–49 h, and genomic DNA was prepared 
for LM-PCR. In agreement with previous fi ndings (11), 
abundant DSBs were detected in WT cells at this time point, 
with very few breaks detectable in identically treated AID-
defi cient cells (Fig. 4 A). Remarkably, 2.3-fold more Sμ DSBs 
were detected in polβ−/− than in WT cells (Fig. 4, A and C). 
A threefold increase in DSBs was observed in the acceptor 
Sγ3 region in polβ−/− cells (Fig. 4, B and C). To ascertain 
whether the increased DSBs in S regions of polβ−/− cells are 
relevant to CSR and are not caused by a nonspecifi c increase 
in DSBs, we assayed DSBs at the Cμ region. Very few breaks 
in the Cμ gene were detected, and no increase was detected 
Figure 3. Pol𝛃−/− cells switch better to IgG1, IgG2a, and IgG3 than 
WT B cells under suboptimal conditions. (A) Representative FACS profi le 
to assay Ig isotypes in transferred CD45.2 cells. WT and polβ−/− splenic 
B cells were induced to switch under suboptimal conditions, as described in 
Materials and methods, for 4 d. Cells were stained with anti-CD45.2 anti-
body and antibodies recognizing different Ig isotypes, followed by FACS 
analysis. FI values are shown. (B) Percentage of switching to the indicated 
isotypes by polβ−/− cells relative to WT cells (set at 100%) under suboptimal 
conditions. The mean of three experiments is shown, and error bars 
represent the SEM. *, P < 0.05; and **, P < 0.01 using the paired t test to 
determine the signifi cance of the CSR difference between WT and polβ−/− 
cells. (C) Western blot of AID expression in total cell extracts from WT 
splenic B cells treated with LPS + IL-4 or LPS + α-δ-dex under optimal and 
suboptimal conditions for the indicated days. (D) Expression level of γ1 and 
γ3 GL transcripts in cells stimulated under optimal and suboptimal condi-
tions for 3 d. RT-PCR was performed as described in Materials and methods.
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in polβ−/− cells (Fig. 4 D). These results clearly demonstrate 
that Polβ is able to repair DSBs induced in Ig S regions dur-
ing CSR, as its absence leads to increased S region DSBs. To 
show that suboptimal conditions indeed reduced the breaks 
in Sμ, LM-PCR was performed to assay DSBs under these 
conditions. The results in Fig. 4 E confi rmed that fewer breaks 
were induced in Sμ under suboptimal conditions.
It was previously shown that AID-dependent DSBs in 
S regions occur preferentially at the G:C bp in WRC/GYW 
AID hotspots (11). We asked if Polβ defi ciency caused devi-
ation of breakpoints from those hotspots. The products of 
LM-PCR were cloned and sequenced to locate the nucleo-
tides at which the DSBs occurred (Table I). In the absence 
of Polβ, nearly all the DSBs are located at the G:C bp, as in 
WT cells, consistent with their introduction by the AID–
UNG–APE pathway. The fraction of DSBs at the G:C 
bp was even greater than in WT cells, but the diff erence 
was not signifi cant. Although this pathway produces SSBs, 
resulting in staggered DSBs, these and previous data suggest 
that the breaks we detect by LM-PCR have been converted 
to blunt DSBs in vivo by fi ll-in DNA synthesis or by exci-
sion (11, 25).
Pol𝛃 defi ciency results in an increased mutation 
frequency and alters the mutation spectrum in S regions
To further assess the function of Polβ during Ig switch, we 
analyzed mutations in recombined Sμ–Sγ3 junctions from 
Polβ-defi cient B cells and compared them with the WT 
controls. Splenic B cells were activated with LPS plus α-δ-
dex to induce CSR to IgG3, and cells were harvested for 
 genomic DNA preparation 4 d later. Recombined Sμ–Sγ3 
DNA junctions were amplifi ed and cloned for sequencing. 
The overall frequency of mutations in the recombined Sμ 
segments from polβ+/+ mice was 29.6 × 10−4, comparable to 
previous observations (11). However, the mutation frequency 
in the same segment of polβ−/− littermate cells was signifi -
cantly higher (51.2 × 10−4; Table II). Particularly striking 
is the fi nding that the increased mutations in polβ−/− mice 
predominantly occurred at the A:T bp, with no signifi cant 
increase at G:C bp (Table II). The same tendency is also true 
for the recombined Sγ3 segment, although the diff erence is 
of borderline signifi cance. We also examined the positions of 
the mutations relative to Sμ–Sγ3 junctions (Fig. S4, available 
at http://www.jem.org/cgi/content/full/jem.20070756/DC1). 
Polβ defi ciency increased mutations in the regions proximal 
Table I. Blunt DSBs in Sμa from pol β−/− and WT littermate splenic B cells occur preferentially at the G:C bp and 
at WRC/GYW hotspots
nt at DSB pol𝛃+/+ pol𝛃−/− Sequenceb
A:T 20%c 6.5% 43.3%
C:G 80% 93.5% 56.7%
Hotspots 50% 41.9% 23.2%
Totald 30 breaks 31 breaks 2,000 nt’s
aSites of DSBs determined with both the 5′ Sμ and 3′ Sμ primers are combined.
bFrequency at which the nt or motif occurs in the Sμ sequence analyzed.
cPercentage of DSBs located at the indicated bp or at the underlined C or G in the WRC/GYW motif.
dTotal number of DSBs analyzed.
Table II. Mutation frequency in recombined Sμ–Sγ3 segments from splenic B cells induced for 4 d with LPS + α-δ-dex
pol𝛃+/+ pol𝛃−/−
Mutation frequency ×10−4 (number) p-valuea
Sμ
 Total mutations 29.6 (60) 51.2 (88) 0.001
 Mutations at A:T 10.4 (21) 23.3 (40) 0.003
 Mutations at G:C 19.2 (39) 27.9 (48) 0.085
 Mutations at AID hotspotb 15.8 (32) 18.6 (32) 0.533
 nt’s analyzed 20,274 17,202
Sγ3
 Total mutations 19.8 (70) 25.1 (94) 0.138
 Mutations at A:T 6.8 (24) 11.2 (42) 0.05
 Mutations at G:C 13 (46) 13.9 (52) 0.762
 Mutations at AID hotspotb 8.8 (31) 8.3 (31) 0.899
 nt’s analyzed 35,364 37,437
aSignifi cance of difference between WT and polβ−/− mutations (Fisher’s exact test).
bMutations within the underlined C or G in the WRC/GYW hotspot motifs.
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to the junction, as well as distal to the junction on the Sμ 
side, suggesting that the function of Polβ during CSR is not 
restricted to processing DNA ends.
Mutations observed in the segment 5′ to unrearranged 
(GL) Sμ segments have been taken to refl ect AID targeting 
to S regions (39–41). If Polβ participates in repairing SSBs 
introduced by the AID–UNG–APE pathway, one would 
predict that Polβ defi ciency will result in increased muta-
tions in the GL Sμ segment. We examined mutations in the 
GL 5′ Sμ segments from activated polβ−/− B cells compared 
with WT B cells. Similar to our results with recombined 
Sμ–Sγ3 junctions, Polβ defi ciency resulted in increased 
mutations, especially at the A:T bp (Table III). The mutation 
spectra for recombined Sμ–Sγ3 and GL 5′ Sμ segments are 
shown in Fig. 5. There are no remarkable diff erences in the 
ratios of transitions/transversions at either the A:T or G:C 
bp between WT and polβ−/− sequences, suggesting that the 
absence of Polβ does not change the specifi c translesion 
polymerases involved in repairing S regions. Together with 
the LM-PCR results, these data unambiguously indicate 
that Polβ is able to repair AID-initiated SSBs in S regions 
during CSR.
We examined the eff ect of Polβ defi ciency on the use of 
microhomologies and the presence of insertions at Sμ–Sγ3 
junctions (Table S2, available at http://www.jem.org/cgi/
content/full/jem.20070756/DC1). Although the overall 
distribution of microhomologies and the average micro-
homology did not notably diff er from that in WT junctions, 
there was a tendency toward a reduction in microhomology 
lengths, and there were considerably decreased insertions at 
the Sμ–Sγ3 junctions. The greater frequency of DSBs in the 
absence of Polβ might result in shorter single-stranded tails at 
the DSBs, which might in turn result in decreased junctional 
microhomologies and insertions.
Figure 4. Increased formation of DSBs at S regions in switching 
Polβ−/− splenic cells. (A and B) Splenic B cells from WT and polβ−/− mice 
were induced to switch under the optimal conditions indicated. At 47–49 h, 
viable cells were isolated, DNA was purifi ed, and LM-PCR was performed to 
identify blunt DSBs. LM-PCR products were blotted and hybridized with the 
indicated probes. PCR amplifi cation of the GAPDH gene is shown below the 
blots as an internal control for template input (threefold dilutions of 1,630 
cell equivalents). (C) Quantifi cation of LM-PCR results by densitometry of 
autoradiographic fi lms, setting WT = 1 (n = 6 for Sμ and 3 for Sγ3); for 
both regions, the differences between WT and polβ−/− cells are statistically 
signifi cant (P < 0.01). The densities of bands from all three lanes for each 
mouse were measured (GeneTools; Syngene). Error bars represent the SEM. 
(D) Cμ LM-PCR products from WT and polβ−/− B cells detected with the 
Cμ probe. These blots are from the same experiment shown in A. (E) LM-
PCR assay shows that fewer DSBs are induced in WT splenic B cells incu-
bated for 2 d under suboptimal rather than under optimal conditions.
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D I S C U S S I O N 
Pol𝛃 is able to repair AID-initiated lesions in S regions 
during CSR
Uracil in DNA is a common form of DNA damage, and effi  -
cient pathways in cells are dedicated to its repair. Normally, 
uracil in DNA is excised by UNG or by single-strand se-
lective monofunctional uracil glycosylase (SMUG1), and less 
frequently by other uracil DNA glycosylases, initiating high-
fi delity repair by the BER pathway (20). A multi-protein 
complex that can perform BER and contains UNG2 (the nuclear 
form of UNG), APE1, Polβ, replicative DNA polymerases 
δ and ε, XRCC1, and DNA ligase I has been isolated from 
both proliferating and growth-arrested HeLa cells, as well as 
from human peripheral blood lymphocytes (42, 43). Further-
more, physical interactions among BER enzymes have been 
shown to increase repair effi  ciency (44–46). These fi ndings 
suggest that BER will proceed to completion once it is 
initiated by UNG. As UNG has been fi rmly established to be 
required for CSR (7, 23, 47), an interesting question arises as 
to whether the AID-instigated lesions in S regions of B cells 
Figure 5. The mutation spectra of S regions do not differ between 
WT and pol𝛃−/− B cells. (A) Mutation spectra in recombined Sμ–Sγ3 
segments. (B) Mutation spectra in 5′ GL Sμ cells. The numbers shown are 
the percentages of total mutations. The numbers of mutations analyzed 
are as shown in Tables II and III.
Table III. Mutation frequency in GL 5′ Sμ segments from splenic B cells induced for 4 d with LPS + α-δ-dex
pol𝛃+/+ pol𝛃−/−
Mutation frequency ×10−4(number) p-valuea
Total mutations 16 (31) 33.1 (75) <0.001
Mutations at A:T 6.7 (13) 18.1 (41) 0.001
Mutations at G:C 9.3 (18) 15 (34) 0.126
Mutations at AID hotspotb 4.1 (8) 9.7 (22) 0.042
nt’s analyzed 19,388 22,634
aSignifi cance of difference between WT and polβ−/− mutations (Fisher’s exact test).
bMutations within the underlined C or G in the WRC/GYW hotspot motifs.
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might be specifi cally prevented from being correctly repaired. 
The results presented in this paper do not support this hypo-
thesis. We fi nd that Polβ expression is induced in nuclei and 
is associated with the Ig Sμ region in mouse splenic B cells 
induced to switch in culture, and that Polβ defi ciency results 
in increased mutations and DSBs in S regions. Our data 
clearly indicate that, at least at the level of Polβ, the BER 
pathway remains competent to repair AID-induced SSBs in 
B cells induced to switch in culture. It is possible, however, 
that B cells in vivo might show diff erent results, as immuno-
histochemical data suggest that Polβ is down-regulated in 
human tonsil germinal centers (28). Furthermore, Polβ defi -
ciency did not appear to have a clear eff ect on SHM of mouse 
V genes during a response to 4-hydroxy-3-nitrophenyl acetyl-
chicken gamma globulin, although there was a reduction of 
the most highly selected amino acid change resulting from 
SHM of the Vh gene (32).
Increased mutations in S regions of Pol𝛃−/− mice
Incubation of the BER complexes from HeLa cells with an 
inhibitory antibody to Polβ decreases their ability to perform 
short-patch (single-nucleotide) repair in vitro (mediated by 
Polβ) and increases long-patch repair mediated by replicative 
polymerases (43). As replicative polymerases are high-fi delity 
polymerases, this substitution would not increase mutation 
frequency. However, we found that the overall frequency 
of mutations in the absence of Polβ increased by 1.7–2.1-fold. 
The mutations increase primarily at the A:T bp but also slightly 
at the G:C bp (Tables II and III). These data are consistent 
with the possibility that there is an increase in the activity of 
error-prone translesion polymerases at Sμ in the absence of 
Polβ, and that the polymerases do not simply add a single 
nucleotide as Polβ usually does but instead perform long-
patch displacement synthesis that continues beyond the original 
excised nucleotide.
Polη is the predominant translesion polymerase that mutates 
the A:T bp in Ig S regions and is recruited by Msh2-Msh6 
(37, 48–53). Polη can also mutate V genes and Sμ in the 
absence of Msh2, although the mutation frequency is much 
reduced, and it is hypothesized that Polη can also be re-
cruited by UNG (53). We hypothesize that Polη is sub-
stituting for Polβ, initiating DNA synthesis from the SSBs 
created by APE activity. Furthermore, because Polη does 
not have the dRP lyase activity that Polβ has, Polη cannot 
perform small-patch repair; i.e., it cannot simply insert one 
nucleotide, because the dRP group would need to be excised 
to complete the repair. Therefore, Polη would most likely 
perform displacement synthesis, explaining the increased mu-
tations at the A:T bp (54). We hypothesize that a translesion 
polymerase substitutes for Polβ rather than a high-fi delity 
polymerase because of the presence of numerous abasic sites 
in the S regions, which will arrest DNA synthesis by high-
 fi delity polymerases.
Although we hypothesize that Polη is substituting for 
Polβ in the polβ−/− cells, it is possible that Polλ might also be 
substituting. Like Polβ, Polλ is a member of the X family of 
DNA polymerases, the only other member known to have 
dRP lyase activity (55). Like Polβ, Polλ protects mouse 
 embryonic fi broblast (MEF) cells against oxidative DNA 
damage (56). Furthermore, Polλ is able to substitute for Polβ 
in the repair of uracils in extracts prepared from MEFs, as 
well as in assays where BER is reconstituted with purifi ed 
proteins (55, 57). However, Polλ coimmunoprecipitates 
with SMUG1 from MEFs and functions after SMUG1 (56), 
whereas SMUG1 does not normally function during CSR 
(23, 58). Furthermore, neither SMUG1 nor Polλ are found 
in the large BER complex isolated from HeLa cells described 
earlier in this section (42, 43). Although Polλ is an error-
prone polymerase, it predominately generates single-nucleotide 
insertion and deletion mutations (59), and we did not observe 
an increase of such mutations in the S regions of polβ−/− 
mice (unpublished data). Collectively, it is unlikely that Polλ 
substitutes for Polβ to repair S region lesions.
The mild CSR phenotype of Pol𝛃-defi cient mice suggests 
that SSBs in S regions are not limiting
The DSBs in both Sμ and Sγ3 regions were increased 2.3–3-fold 
in polβ−/− cells relative to WT cells. However, CSR was 
not increased as much. When we stimulated B cells to switch 
under suboptimal conditions, switching to IgG2a, IgG2b, 
and IgG3 were increased by 1.4–1.8-fold in the absence of 
Polβ, whereas under optimal induction conditions only CSR 
to IgG2a was consistently higher (1.6-fold) in Polβ-defi cient 
B cells. We suggest that Polβ only inhibits CSR when SSBs 
in S regions are limiting. The S regions of the two isotypes 
that are not aff ected by Polβ defi ciency, IgG1 and IgA, have 
more AID hotspots than any of the other acceptor S regions 
(Table S1). Sγ1 has the longest section of tandem repeats, 
9 kb (60), and Zarrin et al. (61) have provided evidence 
that CSR effi  ciency is proportional to S region length. Sα is 
4 kb in length (62) but is highly homologous to Sμ (63) and 
has the highest density of AID target hotspots of all acceptor 
S regions, especially of the AGCT motif (Table S1), which is 
the hottest hotspot (37, 38). In addition, in MMR-defi cient 
B cells, switching to IgG2a is the most reduced (fi vefold), and 
IgG1 and IgA switching are the least reduced of all isotypes 
(64). MMR has been shown to be important for converting 
SSBs to DSBs and is especially important for switching when 
there are very few AID hotspot targets (unpublished data) 
(25, 65). These results are consistent with our hypothesis 
that DNA breaks in Sγ2a are limiting and that Polβ defi -
ciency increases switching to isotypes in which S region 
breaks are limiting.
Polβ possesses two enzymatic activities: polymerase and 
lyase activities. The polymerase function of Polβ can be sub-
stituted by other cellular polymerases, whereas the lyase func-
tion is essential for cell survival from methyl methanesulphonate 
treatment (66). It is therefore expected that in polβ−/− cells, 
DNA breaks in S regions should bear the dRP moiety before 
their ligation. The implication would be that Polβ defi ciency 
increases breaks to potentiate CSR, yet because of remaining 
dRP moieties, this defi ciency might impair ligation effi  ciency 
1686 DNA POLYMERASE β INHIBITS CLASS SWITCHING | Wu and Stavnezer
during end joining. Although the dRP moiety can be removed 
during long-patch repair by the fl ap-endonuclease Fen1 (55, 
67, 68), the dual activities of Polβ complicate the interpretation 
of the CSR phenotype of polβ−/− mice. It is likely that the 
LM-PCR assay is not impaired by the presence of dRP groups, 
as they are extremely labile in vitro (69).
Conclusions
If B cells were to down-regulate BER during CSR, this 
could be dangerous, given the great amount of reactive oxygen 
species produced during B cell activation and proliferation. 
Therefore, it instead seems plausible that a mechanism is adopted 
that endows S regions with such numerous AID targets that 
the ability of BER to repair them is overwhelmed, rather than 
abrogating overall BER ability and thus jeopardizing the integ-
rity of the B cell genome. In fact, examination of mutations in 
ung−/− msh2−/− mice demonstrated that AID introduces many 
more lesions into the Sμ region than result in actual muta-
tions, most likely because of their being correctly repaired in 
WT mice (47). The fi nding that artifi cially introduced I-SceI 
sites in Sμ and Sγ1 regions mediate CSR to IgG1 suggests 
that only a single DSB in the donor and acceptor S regions is 
suffi  cient for CSR (70). Introduction of numerous dU residues 
might be required to obtain DSBs in the donor and acceptor 
S regions simultaneously. These considerations and the ex-
perimental data in this study suggest that Polβ functions normally 
during CSR to repair AID-initiated DNA lesions but that 
the numerous AID lesions overwhelm it, and thus, some breaks 
remain unrepaired.
MATERIALS AND METHODS
Fetal liver transfers. C57BL/6 mice heterozygous for the Polβ gene 
(CD45.2 allotype) were bred to obtain homozygous embryos. 2-mo-old 
C57BL/6 mice with the CD45.1 allotype (strain B6.SJL-Ptprca Pepcb/BoyJ; 
The Jackson Laboratory) were used as recipients for fetal liver transfers. For 
timed pregnancies, the appearance of a vaginal plug after overnight mating 
was labeled as day 0.5 of gestation. Polβ−/−, polβ+/−, and WT FLCs were 
isolated from fetuses of the CD45.2 allotype at day 18.5 postcoitum. Fetuses 
were obtained by intercrossing polβ+/− mice (provided by K. Rajewsky, 
Harvard Medical School, Boston, MA; and S.H. Wilson, National Institute 
of Environmental Health Sciences, Research Triangle Park, NC) of the 
CD45.2 allotype. Mice and fetuses were genotyped by a PCR-based assay. 
Single-cell suspensions of fetal livers were obtained, and 2 × 106 FLCs in 
HBSS (Invitrogen) in a volume of 100 μl were injected intravenously into 
CD45.1 recipient mice, which were lethally irradiated (650 rads) the previ-
ous day. Recipients were treated with antibiotics in their drinking water for 
4 wk after irradiation. Reconstitution of transferred cells was examined 6 wk 
after fetal liver transfer by staining peripheral blood with anti-CD45.1 and 
anti-CD45.2 antibodies, followed by FACS analysis, and was consistently 
≥95%. The mice were bred and used according to the guidelines of the 
University of Massachusetts Animal Care and Use Committee.
B cell isolation and stimulation. Splenic B cells were isolated by T cell 
depletion with antibody and complement, as described previously (71), and 
cultured at 105 cells/ml. For optimal induction conditions, 50 μg/ml LPS 
(for all isotypes; Sigma-Aldrich) and 800 U/ml IL-4 were used to induce 
switch recombination to IgG1; 10 U/ml LPS and IFN-γ were used to 
induce IgG2a switching; 30 μg/ml LPS and dextran sulfate (GE Healthcare) 
were used to induce IgG2b switching; 0.3 ng/ml LPS and α-δ-dex were 
used to induce IgG3 switching; and LPS, 2 ng/ml TGF-β, 800 U/ml IL-4, 
1.5 ng/ml IL-5 (BD Biosciences), and 0.3 ng/ml α-δ-dex were used to 
induce IgA switching. 100 ng/ml BAFF/BLyS (Human Genome Sciences) 
was also included in all cultures. These optimal induction conditions were 
used for induction of CSR in all experiments, except where suboptimal 
conditions are indicated; this includes the LM-PCR, mutation studies, and 
Western blotting experiments. For CFSE labeling, cells were washed in 
serum-free HBSS and resuspended at 40 × 106 cells/ml. An equal volume of 
2.4 μM CFSE was added, and cells were incubated at 37°C for 12 min 
and washed with medium containing 10% FCS. Cells were diluted and 
cultured as described. The suboptimal conditions used were as follows: IgG1 
(5 μg/ml LPS, 80 U/ml IL-4, and 100 ng/ml BAFF), IgG2a (5 μg/ml LPS, 
1 U/ml IFN-γ, and 100 ng/ml BAFF), IgG2b (1 μg/ml LPS and 0.6 μg/ml 
dextran sulfate), IgG3 (1 μg/ml LPS and 0.012 ng/ml α-δ-dex), and IgA 
(0.5 μg/ml LPS, 1 ng/ml TGF-β, and 50 ng/ml BAFF). FACS was 
performed as previously described (11) and analyzed by FlowJo software 
(TreeStar, Inc.).
B cell extracts and Western blotting. The whole-cell lysates and 
 nuclear/cytoplasmic fractions were prepared and analyzed as described pre-
viously, with some modifi cations (72). For whole-cell lysates, cells were lysed 
in solution A (50 mM Tris-HCl [pH 7.8], 420 mM NaCl, 1 mM EDTA, 
0.5% nonidet P-40, 0.34 M sucrose, 10% glycerol, 1 mM Na3VO4, 10 mM 
NaF and β-glycerophosphate, 1 mM PMSF, and protease inhibitor cock-
tail), followed by a brief sonication. Lysates were cleared by centrifugation, 
and protein concentration was determined by the Bradford assay (Bio-Rad 
Laboratories). For nuclear extract preparation, cells were fi rst lysed in buff er 
B (10 mM Hepes [pH 7.9], 10 mM KCl, 1.5 mM MgCl2, 0.34 M sucrose, 
10% glycerol, 0.1% Triton X-100, protease, and phosphatase inhibitors). 
Cytoplasmic proteins were separated from nuclei by low-speed centrifu-
gation (1,300 g for 4 min). Isolated nuclei were washed once with solution 
B and further lysed in solution A, as described. Proteins were separated 
on SDS-polyacrylamide gels and transferred to a polyvinylidene difl uoride 
membrane. The membranes were blocked with TBST buff er containing 
5% powdered milk and probed using the following primary antibodies: 
anti-Polβ (Abcam), GAPDH (Santa Cruz Biotechnology, Inc.), lamin 
A/C (Cell Signaling), and anti-AID antibody (11). The membranes were 
incubated with horseradish peroxidase–linked secondary anti–mouse 
(rabbit) antibodies, and bound antibodies were visualized using enhanced 
chemiluminescence.
ChIP. The reagents used for ChIP were purchased from Upstate Bio-
technology, and the procedures were previously described (73). In brief, one 
million cell equivalents were used per immunoprecipitation with 4 μg anti-
Polβ (Abcam), and 105 cells were used for the input sample. A mixture of 
BSA- and salmon sperm DNA–coated protein A/G agarose beads was used 
for preclearing and for immunoprecipitation. The recovered DNA was 
either amplifi ed by real-time PCR with a Light Cycler (Roche) and SYBR 
Green I (Invitrogen) or by conventional PCR and ethidium bromide stain-
ing. The PCR primers for 5′ of Sμ amplifi ed the segment corresponding to 
positions 137,276–137,376 (available from GenBank/EMBL/DDBJ under 
accession no. AC073553). Primers for Cα are 5′-A T C C C A C C A T C T A C C-
C A C T G A -3′ (forward) and 5′-C G T G C C G G A A G G G A A G T A -3′ (reverse). 
Primers for Cμ are 5′-G T C A G T C C T T C C C A A A T G T C T T C C -3′ (forward) 
and 5′-C T G G A A T G G G C A C A T G C A G A T C T T T -3′ (reverse). The binding 
of Polβ with DNA was calculated by dividing the signal intensity from 
densitometry analysis or the relative quantity obtained from real-time PCR by 
10 times the value obtained for the input sample.
RT-PCR. RNA was isolated from cultured splenic B cells using TriRe-
agent (Ambion) and primed with oligo(dT) for reverse-transcription with 
M-MLV Reverse Transcriptase (Promega). Hypoxanthine phosphoribo-
syltransferase primers include 5′-G T T G G A T A C A G G C C A G A C T T T G T-
T G -3′ (forward) and 5′-T A C T A G G C A G A T G G C C A C A G G A C T A -3′ 
(reverse). GL γ1 primers are 5′-C A G C C T G G T G T C A A C T A G -3′ (forward) 
and 5′-C T G T A C A T A T G C A A G G C T -3′ (reverse). GL γ2a primers are 
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5′-G T C C A C C T T G G T G C T G C T T -3′ (forward) and 5′-G C T G A T G T A C C-
T A C C T G A G A G A G -3′ (reverse). GL γ3 primers are 5′-C A A G T G G A T C T-
G A A C A C A -3′ (forward) and 5′-G G C T C C A T A G T T C C A T T -3′ (reverse).
LM-PCR. Genomic DNA was prepared, and LM-PCR was performed 
as previously described (11). In brief, after 2 d of culture, viable cells were 
isolated by fl otation on Ficoll/Hypaque gradients and embedded in aga-
rose plugs. The plugs were treated with proteinase K and washed to purify 
genomic DNA. For ligation, LM-PCR1 (5′-G C G G T G A C C C G G G A G A-
T C T G A A T T C -3′) and LM-PCR2 (5′-G A A T T C A G A T C -3′) oligonu-
cleotides were used to make the linker. The following primers were 
used in conjunction with the linker-primer (LM-PCR1) to amplify DNA 
breaks: 5′ Sμ, 5′-G C A G A A A A T T T A G A T A A A A T G G A T A C C T C A G-
T G G -3′; 3′ Sμ, 5′-G C T C A T C C C G A A C C A T C T C A A C C A G G -3′; Sγ3, 
5′-A A C A T T T C C A G G G A C C C C G G A G G A G -3′; and Cμ, 5′-C T G C G A-
G A G C C C C C T G T C T G A T A A G -3′. Three-fold dilutions of input DNA 
were amplifi ed by Hotstar Taq (QIAGEN) using a touchdown PCR pro-
gram. The following probes were used for Southern blotting: Sμ probe, 
5′-A G G G A C C C A G G C T A A G A A G G C A A T -3′; Sγ3 probe, 5′-G G A C-
C C C G G A G G A G T T T C C A T G A T C C T G G G -3′; and Cμ probe, 5′-T G G C-
C A T G G G C T G C C T A G C C C G G G A C T T C C T G -3′. PCR products were 
cloned into the vector pCR4-TOPO (Invitrogen) and sequenced by Mac-
rogen using T3 and T7 primers. Cloned breaks in Sμ were aligned with the 
GL Sμ sequence from C57BL/6 chromosome 12 (available from GenBank/
EMBL/DDBJ under accession no. AC073553), with numbering starting 
at nt 136,645 (=1) to locate the breakpoints.
PCR amplifi cation of Sμ–S𝛄3 junctions and GL S𝛍 segments. PCR 
amplifi cation was performed as previously described (41). In brief, genomic 
DNA was isolated from purifi ed splenic B cells cultured for 4 d in the presence 
of LPS plus α-δ-dex. Sμ–Sγ3 junctions were amplifi ed from genomic DNA 
by PCR using the Expand Long Template Taq and Pfu polymerase mix (Roche) 
with the primers μ3-H3 (5′-A A C A A G C T T G G C T T A A C C G A G A T G A-
G C C -3′) and g3-2 (5′-T A C C C T G A C C C A G G A G C T G C A T A A C -3′). 
The primers used for GL 5′ Sμ amplifi cation were 5μ3 (5′-AATGG-
A T A C C T C A G T G G T T T T T A A T G G T G G G T T T A -3′) and 3μ2 (5′-A G A G-
G C C T A G A T C C T G G C T T C T C A A G T A G -3′). The PCR products were 
cloned into the pCR4-TOPO vector (Invitrogen) and sequenced by 
Macrogen. The statistical signifi cance of diff erences between sequences from 
WT and Polβ-defi cient cells was calculated using Fisher’s exact t test.
Online supplemental material. Table S1 shows the lengths and AGCT 
densities of diff erent mouse S regions. Table S2 compares the microhomology 
lengths of Sμ–Sγ3 junctions in Polβ+/+ and Polβ−/− cells. Fig. S1 is a Western 
blot to show that cytoplasmic and nuclear extracts are not cross-contaminated. 
Fig. S2 shows an example of a DNA content analysis of Polβ+/+ and Polβ−/− 
cells during CSR. Fig. S3 presents RT-PCR analyses of GL γ2a and γ1 tran-
scripts in Polβ+/+ and Polβ−/− cells induced to switch to the corresponding 
isotype. Fig. S4 shows the distribution of mutations across Sμ–Sγ3 junctions 
in Polβ+/+ and Polβ−/− cells. Online supplemental material is available at 
http://www.jem.org/cgi/content/full/jem.20070756/DC1.
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